Top of Mind

Perspective on neuroscience from the only global pharmaceutical company fully focused on the brain.

Date Features
December 1, 2016 As part of Lundbeck’s continued commitment to the epilepsy community, we will present 16 posters in a scientific exhibit at the 2016 American Epilepsy Society (AES) Meeting. This infographic shares some of the highlights, including when and where the posters will be displayed at AES. Read more.
September 13, 2016 It is no secret that Parkinson's disease has a devastating effect on the people who are afflicted by it. Lundbeck's Vice President and General Manager of Neurology Lorena Di Carlo shares three reasons she has hope for Parkinson's disease as she gets ready to attend the 4th triennial World Parkinson Congress in Portland. Read more.
September 8, 2016 Despite afflicting more than 5 million U.S. patients – with a sharply expanding number of new diagnoses each year – Alzheimer’s disease remains a mystery to many Americans. In order to spread the word about Alzheimer's disease and build awareness of the devastation it exacts each day, we have created a guide to Alzheimer's fundamentals, from A to Z! Read more.
August 8, 2016 For the first time in more than a decade, the U.S. saw an uptick in mortality in 2015. Lundbeck's Executive Vice President & Global Chief Commercial Officer Staffan Schuberg shares his thoughts on this tragic development, the roots behind it, and where we must go from here. Read more.
July 28, 2016 Lundbeck North America President Peter Anastasiou offered some thoughts on the much needed recent bipartisan progress made to reform our mental health care system. Read more.
June 16, 2016 Dr. Gary Tong, Lundbeck's U.S. Therapeutic Area Head for Dementia, identifies five key challenges to achieving a breakthrough in Alzheimer's disease. Read more.
April 26, 2016 Groups like the World Health Organization and World Bank are currently coming together to address global unmet need in mental healthcare. Lundbeck's Global Chief Commercial Officer Staffan Schuberg offers perspective on the importance of this type of partnership and the urgency of this work. Read more
April 15, 2016 Lundbeck's North America President Peter Anastasiou reflects on the importance of reputation in the pharmaceutical industry. Read more
March 1, 2016 ESPN's Mike Greenberg offered a powerful plea for people to better understand depression for the complicated and devastating disease that it is. Lundbeck's North America President Peter Anastasiou offered his thoughts on the importance of changing the conversation about depression. Read more.
February 29, 2016 Depression is a complicated disease with huge unmet need. Lundbeck's Global Chief Commercial Officer Staffan Schuberg reflects on the progress left to be made. Read more.
February 9, 2016 Dr. Gary Tong, Lundbeck's U.S. Therapeutic Area Head for Dementia, offers perspective on exciting parallels between progress in Alzheimer's research and the "Cancer Moonshot." Read more
November 19, 2015 Lundbeck's Global Chief Commercial Officer Staffan Schuberg offers his thoughts on the current momentum behind addressing the unmet need in mental health. Read more.
September 10, 2015 Lundbeck's Global Chief Commercial Officer Staffan Schuberg offers three necessary principles in the effort to defeat Alzheimer's disease. Read more
July 17, 2015 People often underestimate the complexity of depression and the various ways it impacts patients' lives. Lundbeck's Global Chief Commercial Officer Staffan Schuberg encourages prominent dictionaries to bring their definition of depression in line with the realities of the disease. Read more.
May 13, 2015 Lundbeck's Global Chief Commercial Officer Staffan Schuberg's perspective on the global approach we must take to brain research. Read more
April 23, 2015 Lundbeck's Global Chief Commercial Officer Staffan Schuberg shares three insights on driving a patient-focused approach to business. Read more

 

Alzheimer's From A to Z

Despite afflicting more than 5 million U.S. patients – with a sharply expanding number of new diagnoses each year – Alzheimer’s disease remains a mystery to many Americans. In order to spread the word about Alzheimer's disease and build awareness of the devastation it exacts each day, we have created a guide to Alzheimer's fundamentals, from A to Z! Read more.

Five Key Challenges to Achieving a Breakthrough in Alzheimer’s Disease

Dr. Gary Tong, U.S. Therapeutic Area Head of Dementia at Lundbeck identifies five key challenges to achieving a breakthrough in Alzheimer's disease.

Read more.

VIDEO

Studio E: The Epilepsy Art Therapy Program

Caring for people with brain disorders goes far beyond medication.

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit. Click OK to continue or Cancel to return to Lundbeck.